Aging of the Vascular Wall

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Hospitalier Universitaire de Saint Etienne

About this trial

Demographic aging is predicted to be one of the most significant social changes of the 21st century. Aging is a slow, multifactorial process that progressively impacts the integrity of cells, tissues, and organs. This decline in function increases the risk of numerous diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases (CVD). CVD, the leading global cause of death, becomes more prevalent with age. Aging contributes to endothelial dysfunction, vessel stiffness, thickening, and impaired platelet function. These changes disrupt hemostatic processes and increase the risk of cardiovascular complications. Despite preventive strategies CVD remain a major public health challenge. Cellular aging, or senescence, affects all cell types, particularly endothelial cells and platelets. However, little research has compared the aging rates of different blood vessel types, such as arteries and veins. Given their distinct compositions and developmental origins, it is likely that their aging processes differ at molecular, cellular, and physiological levels.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Major patients requiring coronary artery bypass grafting (CABG).

Disqualifiers

Hypertension, diabetes, systemic inflammatory disease.

Trial population

Patients requiring coronary artery bypass grafting (CABG).

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Graft collection

    Procedure/Surgery

    Sampling of superior venous and arterial grafts (internal mammary artery, great saphenous vein) after coronary artery bypass surgery.

Treatment groups

30 Participants
are divided into 3 treatment groups
Group A: Youngs1 intervention
Group B: Middle-aged1 intervention
Group C: Elderly1 intervention

Trial outcomes

Primary outcomes

1

Biomarkers of ageing

Detection of innovative biomarkers of ageing by microscope analysis.

Time frame
Day 1

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.